glp-1 gip and receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell function GLP-1 and GIP receptor signaling

These medications are approved by the Food and Drug Administration (FDA) for the treatment of obesity or overweight with weight-related comorbidities

Davies, L

Move GLP-1s to the Pharmacy Benefit Many GLP-1s administered in a clinical setting are billed under the medical benefit, where visibility and control are limited

doi: 10.1007/s00223-014-9949-1 88 SinnemaMMaaskantMAvan Schrojenstein Lantman-de ValkHMJvan NieuwpoortICDrentMLCurfsLMGet al

Endocrine regulation of central GLP-1 secretion As discussed above, in addition to enteroendocrine L-cells, GLP-1 is also produced in a discrete set of non-TH-positive neurons in the caudal portions of the NTS [86,148,[346], [347], [348]], and these hindbrain GCG + positive neurons are the primary source of endogenous brain GLP-1 [90]

Look out for quality and safety issues